Penn Medicine is conducting medical studies to develop new diagnostic and clinical treatments to improve current standards of care.
Search By Keywords
Example: Diabetes, Cardiology, John Smith
Browse by Disease or Condition
Recently Added/Updated Trials
-
Efficacy, Safety, and Tolerability Topical Nasal Spray in the Prevention of SARS-CoV-2 Infection in Healthcare Personnel
The purpose of this study is to assess the effectiveness, safety, and tolerability of GLS-1200 to prevent SARS-CoV-2 infection in healthcare personnel. GLS-1200 contains ...Read more -
Autism Spectrum Program of Excellence
The goal of the ASPE study is to investigate the genetic basis of Autism spectrum disorder (ASD) and autism-related traits.Individuals 3 years old or ...Read more -
Healthy volunteers for Neuroinflammatory research study
We are conducting research studies on how immune system cells contribute to inflammatory conditions of the nervous system, such as multiple sclerosis, neuromyelitis optica (NMO ...Read more -
Telemedicine vs in-person delivery of cognitive behavioral treatment of insomnia: a mixed methods analysis
Cognitive behavioral therapy for insomnia (CBT-I) has been the gold standard for the treatment of insomnia. There is a need to increase access to treatment ... Read more
-
Propranolol Rescue of Prolonged Labor
Over 30% of all cesarean deliveries (CD) performed in the United States are for prolonged labor. Current management strategies to resolve prolonged labor fail up ... Read more
-
Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19
Read moreHVTN 405/HPTN 1901 will describe immune responses in study participants with a history of recovering from SARS- CoV-2 infection. A main aim of HVTN ... -
Study Of Oral Ozanimod As Induction Therapy For Moderately To Severely Active Crohn’s Disease
Have you been diagnosed with or have signs and symptoms of moderately to severely active Crohn’s disease (CD)? Have you not improved on or ... Read more
-
TRaCkLIGHT study for people with moderate to severe Crohn's Disease
Patients with moderate to severe Crohn's disease, who have failed prior treatment with the standard anti-TNF therapy will receive the study medication - MDGN-002 - which ... Read more
